ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer(TNBC) is a subtype of breast cancer, which accounts for approximately 15–25% of breast cancer cases and is characterized by the absence or reduction of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) [2].